Stock Chart
ARQT
Type: SELL growth_1yr
Strike: $25
Premium: $11.72
Expiry: Jan 15, 2027
Target: $20
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About ARQT - Arcutis Biotherapeutics, Inc. Common Stock
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
Key Statistics
More ARQT Analysis
This ARQT stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ARQT's price movements with trendlines, gamma walls, and key support/resistance levels.